Find information on medical topics, symptoms, drugs, procedures, news and more, written for the health care professional.

* This is a professional Version *

Evaluation of Anemia

by Alan E. Lichtin, MD

Anemia is not a diagnosis; it is a manifestation of an underlying disorder. Thus, even mild, asymptomatic anemia should be investigated so that the primary problem can be diagnosed and treated.

Acute or chronic blood loss is the first consideration. The diagnosis usually is based on history, examination, and a stool test for occult blood. Further testing for occult bleeding is sometimes necessary.

If blood loss is not detected, laboratory testing is usually done to determine whether anemia is due to deficient RBC production or excessive hemolysis.

History

The history should address risk factors for particular anemias, symptoms of anemia itself, and symptoms that reflect the underlying disorder.

Anemia has many risk factors. For example, a vegan diet predisposes to vitamin B 12 deficiency anemia, whereas alcoholism increases the risk of folate deficiency anemia. A number of hemoglobinopathies are inherited, and certain drugs predispose to hemolysis. Cancer, rheumatic disorders, and chronic inflammatory disorders can suppress bone marrow activity or enlarge the spleen.

The symptoms of anemia are neither sensitive nor specific and do not help differentiate between types of anemias. Symptoms reflect compensatory responses to tissue hypoxia and usually develop when Hb falls to < 7 g/dL. However, they may develop at higher Hb levels in patients with limited cardiopulmonary reserve or in whom the anemia developed very rapidly. Symptoms such as weakness, seeing spots, fatigue, drowsiness, angina, syncope, and dyspnea on exertion can indicate anemia. Vertigo, headache, pulsatile tinnitus, amenorrhea, loss of libido, and GI complaints may also occur. Heart failure or shock can develop in patients with severe tissue hypoxia or hypovolemia.

Certain symptoms may suggest the cause of the anemia. For example, melena, epistaxis, hematochezia, hematemesis, or menorrhagia indicates bleeding. Jaundice and dark urine, in the absence of liver disease, suggest hemolysis. Weight loss may suggest cancer. Diffuse severe bone or chest pain may suggest sickle cell disease, and stocking-glove paresthesias may suggest vitamin B 12 or folate deficiency.

Physical Examination

Complete physical examination is necessary. Signs of anemia itself are neither sensitive nor specific; however, pallor is common with severe anemia.

Signs of underlying disorders are often more diagnostically accurate than are signs of anemia. Heme-positive stool identifies GI bleeding. Hemorrhagic shock (eg, hypotension, tachycardia, pallor, tachypnea, diaphoresis, confusion—see Shock) may result from acute bleeding. Jaundice may suggest hemolysis. Splenomegaly may occur with hemolysis, hemoglobinopathy, connective tissue disease, myeloproliferative disorder, infection, or cancer. Peripheral neuropathy suggests vitamin B 12 deficiency. Abdominal distention in a patient with blunt trauma suggests acute hemorrhage. Petechiae develop in thrombocytopenia or platelet dysfunction. Fever and heart murmurs suggest infectious endocarditis, a possible cause of hemolysis. Rarely, high-output heart failure develops as a compensatory response to anemia-induced tissue hypoxia.

Testing

  • CBC with WBC and platelets

  • RBC indices and morphology

  • Reticulocyte count

  • Peripheral smear

  • Sometimes bone marrow aspiration and biopsy

Laboratory evaluation begins with a CBC, including WBC and platelet counts, RBC indices and morphology (MCV, MCH, MCHC, RBC volume distribution width [RDW]), and examination of the peripheral smear. Reticulocyte count demonstrates how well the bone marrow compensates for the anemia. Subsequent tests are selected on the basis of these results and on the clinical presentation. Recognition of general diagnostic patterns can expedite the diagnosis (see Characteristics of Common Anemias).

Characteristics of Common Anemias

Etiology or Type

Morphologic Changes

Special Features

Blood loss, acute

Normochromic-normocytic, with polychromatophilia

Hyperplastic marrow

If severe, possible nucleated RBCs and left shift of WBCs

Leukocytosis

Thrombocytosis

Blood loss, chronic

Same as iron deficiency

Same as iron deficiency

Folate deficiency

Same as vitamin B 12 deficiency

Serum folate < 5 ng/mL (< 11 nmol/L)

RBC folate < 225 ng/mL RBCs (< 510 nmol/L)

Nutritional deficiency and malabsorption (in sprue, pregnancy, infancy, or alcoholism)

Hereditary spherocytosis

Spheroidal microcytes

Normoblastic erythroid hyperplasia

Increased mean RBC Hb level

Increased RBC fragility

Shortened survival of labeled RBCs

Increased radioactivity of spleen (exceeds that of liver)

Hemolysis, acute

Normochromic-normocytic

Reticulocytosis

Marrow erythroid hyperplasia

Increased serum bilirubin and LDH

Increased stool and urine urobilinogen

Hemoglobinuria in fulminating cases

Hemosiderinuria

Hemolysis, chronic

Normochromic-normocytic

Reticulocytosis

Marrow erythroid hyperplasia

Basophilic stippling (especially in lead poisoning)

Increased serum bilirubin and LDH

Shortened RBC life span

Increased radioiron turnover

Hemosiderinuria

Infection or chronic inflammation

Normochromic-normocytic early, then microcytic

Normoblastic marrow

Normal iron stores

Decreased serum iron

Decreased total iron-binding capacity

Normal serum ferritin

Normal marrow iron content

Iron deficiency

Microcytic, with anisocytosis and poikilocytosis

Reticulocytopenia

Hyperplastic marrow, with delayed hemoglobination

Possible achlorhydria, smooth tongue, and spoon nails

Absent stainable marrow iron

Low serum iron

Increased total iron-binding capacity

Low serum ferritin

Marrow failure

Normochromic-normocytic (may be macrocytic)

Reticulocytopenia

Failed marrow aspiration (often) or evident hypoplasia of erythroid series or of all elements

Idiopathic (> 50%) or secondary to exposure to toxic drugs or chemicals (eg, chloramphenicol, quinacrine, hydantoins, insecticides)

Marrow replacement (myelophthisis)

Anisocytosis and poikilocytosis

Nucleated RBCs

Early granulocyte precursors

Marrow aspiration possibly failing or showing leukemia, myeloma, or metastatic cells

Marrow infiltration with infectious granulomas, tumors, fibrosis, or lipid histiocytosis

Possible hepatomegaly and splenomegaly

Possible bone changes

Radioiron uptake greater over spleen and liver than over sacrum

Paroxysmal cold hemoglobinuria

Normochromic-normocytic

Follows exposure to cold

Results from a cold agglutinin or hemolysin

Often associated with syphilis or other infections

Paroxysmal nocturnal hemoglobinuria

Normocytic (may be hypochromic because of iron deficiency)

Marrow may be hypercellular or hypocellular

Dark morning urine

Hemosiderinuria

Positive acid hemolysis (Ham test) and sugar-water tests (mostly replaced by flow cytometric testing)

Sickle cell anemia

Anisocytosis and poikilocytosis

Some sickle cells in peripheral smear

Sickling of all RBCs in preparation with hypoxia or hyperosmolar exposure

Largely limited to blacks

Urinary isosthenuria

Hb S detected during electrophoresis

Possibly painful vaso-occlusive crises and leg ulcers

Bone changes on x-ray

Sideroblastic anemia

Usually hypochromic but dimorphic with normocytes and macrocytes

Hyperplastic marrow, with delayed hemoglobination

Ringed sideroblasts

Inborn or acquired metabolic defect

Stainable marrow iron (plentiful)

Response to vitamin B 6 administration (rare)

Commonly part of myelodysplastic syndrome

Thalassemia

Microcytic

Thin cells

Target cells

Basophilic stippling

Anisocytosis and poikilocytosis

Nucleated RBCs in homozygotes

Decreased RBC fragility

Elevated Hb A 2 and Hb F (often)

Mediterranean ancestry (common)

In homozygotes, anemia from infancy

Splenomegaly

Bone changes on x-ray

Vitamin B 12 deficiency

Oval macrocytes

Anisocytosis

Reticulocytopenia

Hypersegmented WBCs

Megaloblastic marrow

Serum B 12 < 180 pg/mL (< 130 pmol/L)

Frequent GI and CNS involvement

Positive Schilling test (although no longer done)

Elevated serum bilirubin

Increased LDH

Antibodies to intrinsic factor in serum (common)

Sometimes absent gastric intrinsic factor secretion

The automated CBC directly measures Hb, RBC count, and MCV (a measure of RBC size). Hct (a measure of the percentage of blood made up of RBCs), MCH (a measure of the Hb content in individual RBCs), and MCHC (a measure of the Hb level in individual RBCs) are calculated values. The diagnostic criterion for anemia in men is Hb < 14 g/dL, Hct < 42%, or RBC < 4.5 million/μL; for women, Hb < 12 g/dL, Hct < 37%, or RBC < 4 million/μL. For infants, normal values vary with age, necessitating use of age-related tables. RBC populations are termed microcytic (small cells) if MCV is < 80 fL, and macrocytic (large cells) if MCV is > 100 fL. However, because reticulocytes are also larger than mature red cells, large numbers of reticulocytes can elevate the MCV and not represent an alteration of RBC production. Automated techniques can also determine the degree of variation in RBC size, expressed as the RDW. A high RDW may be the only indication of simultaneous microcytic and macrocytic disorders (or simultaneous microcytosis and reticulocytosis); such a pattern may result in a normal MCV, which measures only the mean value. The term hypochromia refers to RBC populations in which MCH is < 27 pg/RBC or MCHC is < 30%. RBC populations with normal MCH and MCHC values are normochromic.

The RBC indices can help indicate the mechanism of anemia and narrow the number of possible causes. Microcytic indices occur with altered heme or globin synthesis. The most common causes are iron deficiency, thalassemia, and related Hb-synthesis defects. In some patients with anemia of chronic disease, the MCV is microcytic or borderline microcytic. Macrocytic indices occur with impaired DNA synthesis (eg, due to vitamin B 12 or folate deficiencies or chemotherapeutic drugs such as hydroxyurea and antifolate agents) and in alcoholism because of abnormalities of the cell membrane. Acute bleeding may briefly produce macrocytic indices because of the release of large young reticulocytes. Normocytic indices occur in anemias resulting from deficient erythropoietin (EPO) or inadequate response to it (hypoproliferative anemias). Hemorrhage, before iron deficiency develops, usually results in normocytic and normochromic anemia unless the number of large reticulocytes is excessive.

The peripheral smear is highly sensitive for excessive RBC production and hemolysis. It is more accurate than automated technologies for recognition of altered RBC structure, thrombocytopenia, nucleated RBCs, or immature granulocytes and can detect other abnormalities (eg, malaria and other parasites, intracellular RBC or granulocyte inclusions) that can occur despite normal automated blood cell counts. RBC injury may be identified by finding RBC fragments, portions of disrupted cells (schistocytes), or evidence of significant membrane alterations from oval-shaped cells (ovalocytes) or spherocytic cells. Target cells (thin RBCs with a central dot of Hb) are RBCs with insufficient Hb or excess cell membrane (eg, due to hemoglobinopathies or liver disorders). The peripheral smear can also reveal variation in RBC shape (poikilocytosis) and size (anisocytosis).

The reticulocyte count is expressed as the percentage of reticulocytes (normal range, 0.5 to 1.5%) or as the absolute reticulocyte count (normal range, 50,000 to 150,000/μL). Higher values indicate excessive production, or reticulocytosis; in the presence of anemia, reticulocytosis suggests excessive RBC destruction. Low numbers in the presence of anemia indicate decreased RBC production. The reticulocyte response can usually be estimated based on the number of blue-stained cells found when the peripheral smear is stained with a supravital stain; this estimate makes a reticulocyte count, which requires flow cytometry or a large amount of time, unnecessary.

Bone marrow aspiration and biopsy provide direct observation and assessment of RBC precursors. The presence of abnormal maturation (dyspoiesis) of blood cells and the amount, distribution, and cellular pattern of iron content can be assessed. Bone marrow aspiration and biopsy are done to diagnose the following conditions:

  • Unexplained anemias

  • Other cytopenias

  • Unexplained leukocytosis

  • Thrombocytosis

  • Suspected leukemia, multiple myeloma, or myelophthisis

Cytogenetic and molecular analyses can be done on aspirate material in hematopoietic or other tumors or in suspected congenital lesions of RBC precursors (eg, Fanconi anemia). Flow cytometry can be done in suspected lymphoproliferative or myeloproliferative states to define the immunophenotype. Bone marrow aspiration and biopsy are not technically difficult and do not pose significant risk of morbidity. These procedures are safe and helpful when hematologic disease is suspected. Both usually can be done as a single procedure. Because biopsy requires adequate bone depth, the sample is usually taken from the posterior (or, less commonly, anterior) iliac crest. If only aspiration is necessary, the sternum may be used.

Serum bilirubin and LDH can sometimes help differentiate between hemolysis and blood loss; both are elevated in hemolysis and normal in blood loss. Other tests are discussed under specific anemias and bleeding disorders (see Evaluation of Anemia : Testing).

Resources In This Article

Drugs Mentioned In This Article

  • Drug Name
    Select Trade
  • HYDREA
  • No US brand name

* This is a professional Version *